Astrazeneca Plc ADR (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AZN | ABBV | NVS | ||
| Company | Astrazeneca Plc ADR | Abbvie Inc | Novartis Ag ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | ||
| Open | 70.43 | 168.59 | 98.74 | ||
| High | 71.10 | 170.37 | 99.50 | ||
| Low | 70.16 | 168.22 | 97.03 | ||
| Last | 70.85 | 169.54 | 97.28 | ||
| Change | +0.72 | +1.65 | +2.16 | ||
| % Change | +1.03% | +0.98% | +2.27% | ||
| Volume | 5,806,000 | 4,084,100 | 3,837,400 | ||
| 20-Day Average Volume | 5,391,130 | 5,270,200 | 1,827,695 | ||
| Previous Close | 70.13 | 167.89 | 95.12 | ||
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 68.21 | 170.70 | 94.94 | ||
| 20-Day Raw Stochastic | 95.31% | 42.78% | 68.95% | ||
| 20-Day Relative Strength | 65.82% | 47.16% | 51.67% | ||
| Weighted Alpha | +1.21 | +15.10 | -5.18 | ||
| Today's Opinion | 72% Buy | 40% Buy | 72% Sell | ||
| Previous Opinion | 56% Buy | 40% Buy | 72% Sell | ||
| Last Month's Opinion | 16% Buy | 80% Buy | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.79% since 04/16/24 | +4.31% since 04/16/24 | +4.38% since 04/16/24 | ||
| Low | 68.13 on 04/19/24 | 163.23 on 04/17/24 | 92.35 on 04/18/24 | ||
| High | 71.10 on 04/23/24 | 170.37 on 04/23/24 | 99.50 on 04/23/24 | ||
| 1-Month | |||||
| %Chg | +6.93% since 03/22/24 | -4.99% since 03/22/24 | +1.09% since 03/22/24 | ||
| Low | 65.76 on 03/26/24 | 160.00 on 04/12/24 | 92.35 on 04/18/24 | ||
| High | 71.10 on 04/23/24 | 182.30 on 03/28/24 | 99.50 on 04/23/24 | ||
| 3-Month | |||||
| %Chg | +6.14% since 01/23/24 | +1.22% since 01/23/24 | -9.70% since 01/23/24 | ||
| Low | 60.47 on 02/12/24 | 160.00 on 04/12/24 | 92.35 on 04/18/24 | ||
| High | 71.10 on 04/23/24 | 182.89 on 03/12/24 | 108.43 on 01/24/24 | ||
| 6-Month | |||||
| %Chg | +12.37% since 10/23/23 | +17.14% since 10/23/23 | +2.74% since 10/23/23 | ||
| Low | 60.47 on 02/12/24 | 135.85 on 11/09/23 | 92.19 on 10/27/23 | ||
| High | 71.10 on 04/23/24 | 182.89 on 03/12/24 | 108.78 on 01/22/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 217,434,064 | 297,273,920 | 194,425,280 | ||
| Shares Outstanding, K | 3,100,443 | 1,770,647 | 2,044,000 | ||
| Annual Sales | 45,811,000,000 | 54,318,000,000 | 46,660,000,000 | ||
| Annual Net Income | 5,955,000,000 | 4,863,000,000 | 14,850,000,000 | ||
| Last Quarter Sales | 12,024,000,000 | 14,301,000,000 | 7,424,000,000 | ||
| Last Quarter Net Income | 960,000,000 | 822,000,000 | 8,480,000,000 | ||
| 60-Month Beta | 0.50 | 0.58 | 0.54 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.73 on 02/08/24 | 2.79 on 02/02/24 | 1.53 on 01/31/24 | ||
| Latest Earnings Date | 04/25/24 | 04/26/24 | 04/23/24 | ||
| Most Recent Dividend | 0.965 on 02/22/24 | 1.550 on 04/12/24 | 2.431 on 03/07/24 | ||
| Next Ex-Dividends Date | 02/22/24 | 04/12/24 | 03/07/24 | ||
| Ratios | |||||
| Price/Earnings ttm | 18.83 | 14.98 | 13.86 | ||